Therefore, the experiment was not performed here; (4) SREBP1c-PNPLA3 pathway has been regarded as a “disease module” that promotes hepatic fibrogenesis [94] while the latter is associated with the progression of NASH. Here, PNPLA3 is linked to metabolic dysfunction-associated steatohepatitis.